← Back to Search

Behavioral Intervention

In-Person vs Telehealth Cardiac Rehab for Heart Disease

N/A
Recruiting
Led By Alexis Beatty, MD, MAS
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 or older
Able to communicate in English or Spanish
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights

Study Summary

This trial will compare 2 methods of delivering cardiac rehab: in-person and via telehealth, to see if they have the same effects and who benefits more from one or the other.

Who is the study for?
This trial is for adults over 18 who need cardiac rehabilitation and have had a recent heart-related event or procedure, like a heart attack or surgery. They must be able to attend rehab sessions in-person or via telehealth and communicate in English or Spanish. People with unstable arrhythmias making exercise risky, those deemed unsafe by the investigator, hospice patients, or anyone unable to consent cannot join.Check my eligibility
What is being tested?
The study compares two ways of doing cardiac rehab: traditional in-person visits versus remote participation through telehealth. It aims to see if one method is more effective than the other and whether certain patients might benefit more from either approach.See study design
What are the potential side effects?
Cardiac rehabilitation typically doesn't involve medication so it's not associated with typical drug side effects. However, participants may experience physical discomfort from exercise or psychological distress during counseling.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I can communicate in English or Spanish.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in six minute walk distance
Secondary outcome measures
Blood pressure control
Change in GAD-7
Change in Generalized Anxiety Disorder (GAD)-7
+7 more

Trial Design

2Treatment groups
Active Control
Group I: In-person cardiac rehabilitationActive Control1 Intervention
Participants will participate in 12-week in-person cardiac rehabilitation as delivered at the site where they are enrolled. The typical course is 36 sessions of group exercise, health education, and counseling over 12 weeks.
Group II: Telehealth cardiac rehabilitationActive Control1 Intervention
Participants will participate in 12-week telehealth cardiac rehabilitation. The program will follow the same core components as in-person cardiac rehabilitation, but in-person supervised exercise will not be required. The core element of telehealth cardiac rehabilitation is 12 weekly individual telehealth sessions between the patient and cardiac rehabilitation provider.

Find a Location

Who is running the clinical trial?

University of PittsburghOTHER
1,723 Previous Clinical Trials
16,342,640 Total Patients Enrolled
11 Trials studying Coronary Artery Disease
8,308 Patients Enrolled for Coronary Artery Disease
Patient-Centered Outcomes Research InstituteOTHER
551 Previous Clinical Trials
29,996,942 Total Patients Enrolled
Johns Hopkins UniversityOTHER
2,266 Previous Clinical Trials
14,836,981 Total Patients Enrolled
27 Trials studying Coronary Artery Disease
56,063 Patients Enrolled for Coronary Artery Disease

Media Library

In-person cardiac rehabilitation (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05933083 — N/A
Coronary Artery Disease Research Study Groups: In-person cardiac rehabilitation, Telehealth cardiac rehabilitation
Coronary Artery Disease Clinical Trial 2023: In-person cardiac rehabilitation Highlights & Side Effects. Trial Name: NCT05933083 — N/A
In-person cardiac rehabilitation (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05933083 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many venues is this investigation directed at?

"This trial is making use of Johns Hopkins University Medical Center in Baltimore, Maryland, the University of Michigan at Ann Arbor, and the UPMC in Pittsburgh to recruit participants. Additionally there are 4 other sites where patients can be involved."

Answered by AI

Is there still room for participants in this clinical experimentation?

"As per the recent updates to clinicaltrials.gov, this particular medical trial is not in search of any new patients anymore—the study was first posted on July 17th 2023 and most recently edited June 27th 2023. Fortunately there are 921 other studies actively recruiting participants right now."

Answered by AI
~344 spots leftby Oct 2026